Moreover, elevated levels of Tim-3 and Galectin-9 in plasma exosomes from NSCLC patients were considered as promising candidates for NSCLC diagnosis and prognosis, highlighting their correlation with an aggressive cancer phenotype [172]. This evidence concerns the gene HAVCR2 and non-small cell lung carcinoma.